683 Capital Management »

In8bio shares owned by 683 Capital Management

Quarter-by-quarter ownership of In8bio (INAB) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in In8bio

Tip: Access up to 7 years of quarterly data

All positions including In8bio held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in In8bio by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.7M 725k 2.34

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. Put Option (LLY)
Capital One Financial (COF)
Tesla Motors Put Option (TSLA)
NVIDIA Corporation Put Option (NVDA)
Wave Life Sciences SHS (WVE)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Alnylam Pharmaceuticals (ALNY)
Praxis Precision Medicines I Com New Put Option (PRAX)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Protagonist Therapeutics (PTGX)
Gxo Logistics Incorporated Common Stock (GXO)
Hilton Grand Vacations (HGV)
Anaptysbio Inc Common (ANAB)

View all positions for 683 Capital Management

Top funds holding In8bio

Alyeska Investment Group
Franklin Resources
683 Capital Management
BIOS Capital Management
Stonepine Capital Management
Two Sigma Investments
Two Sigma Advisers
Vanguard Group
Citadel Advisors
Texas Capital Bank Wealth Management Services
Geode Capital Management
Captrust Financial Advisors
Northern Trust
XTX Topco
Hrt Financial

View all funds holding In8bio